122 results
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
3 Jun 24
Additional proxy soliciting materials
6:28pm
with applicable securities laws as to the disclosure and resale obligations of each Participant is the responsibility of such participant
8-K
oj6j2u2 fpn
5 Jan 24
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2023 Net Revenue Results
6:02am
PX14A6G
wk8wbg
26 Apr 23
Letter to shareholders
10:20am
DEFA14A
pv0yt5g7375wi
18 Apr 22
Additional proxy soliciting materials
7:36am
S-3ASR
EX-5.1
kbsmaj r9l
19 Nov 21
Automatic shelf registration
5:04pm
S-3ASR
EX-4.6
324fh1iovyzjvm97n
19 Nov 21
Automatic shelf registration
5:04pm
S-3ASR
EX-1.2
7o5z3
19 Nov 21
Automatic shelf registration
5:04pm
S-3ASR
j0v27a510k8p ud
19 Nov 21
Automatic shelf registration
5:04pm